NCT03712423View on ClinicalTrials.gov

PET Study With [89Zr]-Df-CriPec® Docetaxel

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

March 25, 2020

Study Completion Date

May 8, 2020

Conditions
Solid Tumor
Interventions
DRUG

Cripec Docetaxel

89 Zirconium Cripec Docetaxel PET

Trial Locations (1)

1081 HV

VU University Medical Center, Amsterdam

Sponsors

Collaborators (1)

Cristal Therapeutics
All Listed Sponsors
collaborator

Cristal Therapeutics

INDUSTRY

lead

Amsterdam UMC, location VUmc

OTHER